Background Dipeptidyl peptidase 3 (DPP3) is a cytosolic enzyme involved in the degradation
of various cardiovascular and endorphin mediators. High levels of circulating DPP3 (…

An increasing number of biological processes appear to be regulated by Pro-specific N-terminal
processing. The proline-specific dipeptidyl peptidases (DPPs) like DPPIV, fibroblast …

… dipeptidyl peptidase 3 (cDPP3) is a novel biomarker that shows a strong association with
organ failure … patient survival and organ failure following open and endovascular TAAA repair. …

… Circulating dipeptidyl peptidase 3 (cDPP3) is a metallo-peptidase involved in the … The link
between cDPP3 levels and the occurrence of shock and organ failure is not clear. Clinical and …

… of organ dysfunction and mortality. In this review, we focus on dipeptidyl peptidase 3 (DPP3) …
All these factors ultimately contribute to the development of organ failure, which is the key …

… While the prognosis of burn patients has improved, the mortality of most severe patients
remains high with many patients dying from circulatory failure and multiple organ failure [16, 17]. …

… chronic diseases eventually resulting in fatal organ failure. Due to the excruciating disease
… and the associated rates of organ failure in multiple disease entities of chronic organ injury. …

… potential of circulating dipeptidyl peptidase 3 (cDPP3) to predict mortality and development
of organ … The association of cDPP3 levels with 30-day mortality and Sequential Organ Failure …

… dipeptidyl peptidase IV (DPPIV) inhibition improves cardiac perfusion and inflammation in an
experimental model of heart failure (… dipeptidyl peptidase IV (DPPIV), also known as CD26, …

Dipeptidyl peptidase IV (DPPIV) is a widely expressed multifunctional serine peptidase that
exists as a membrane-anchored cell surface protein or in a soluble form in the plasma and …